BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $439,000 | -51.8% | 3,700 | -43.9% | 0.00% | -33.3% |
| Q4 2021 | $910,000 | +39.4% | 6,600 | +40.4% | 0.01% | -14.3% |
| Q3 2021 | $653,000 | +68.3% | 4,700 | +17.5% | 0.01% | +75.0% |
| Q2 2021 | $388,000 | +67.2% | 4,000 | +17.6% | 0.00% | +100.0% |
| Q1 2021 | $232,000 | -37.1% | 3,400 | -20.9% | 0.00% | -50.0% |
| Q4 2020 | $369,000 | +57.7% | 4,300 | +19.4% | 0.00% | +33.3% |
| Q3 2020 | $234,000 | -25.5% | 3,600 | -16.3% | 0.00% | -25.0% |
| Q2 2020 | $314,000 | -59.8% | 4,300 | -71.7% | 0.00% | -55.6% |
| Q1 2019 | $782,000 | – | 15,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |